Serum Aldosterone Concentration and Cardiovascular Risk in Women with Polycystic Ovarian Syndrome
Authors:
Open Access
- 1 November 2006
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (11) , 4395-4400
Abstract
Context: Polycystic ovary syndrome (PCOS) is associated with early impairment of vascular structure and a low-grade chronic inflammation. Aldosterone is a well-recognized cardiovascular risk (CVR) factor and is related to inflammatory processes. Objective: Our objective was to investigate serum aldosterone levels in PCOS and correlate them to some CVR factors and early atherosclerotic markers. Design and Setting: A prospective baseline-controlled clinical study was conducted at the University “Federico II” of Naples School of Medicine (Naples, Italy). Patients: Fifty PCOS women age- and body mass index-matched with 50 healthy women were enrolled. Mean Outcome Measures: Anthropometric, hormonal, and metabolic patterns, including plasma aldosterone, renin, and C-reactive protein, were measured in each subject. Intima-media thickness was also evaluated in each patient and control. Results: Aldosterone levels were significantly increased (P < 0.001) in PCOS compared with healthy women (10.5 ± 3.2 vs. 5.7 ± 2.5 ng/dl). In PCOS, a significant (P < 0.001) direct correlation between plasma aldosterone and homeostasis model assessment, C-reactive protein, intima-media thickness, and mean blood pressure was found. On the other hand, high-density lipoprotein cholesterol and potassium were inversely (P < 0.001) related to serum aldosterone. Multiple linear regression analysis showed that the area under the curve for insulin and homeostasis model assessment was linearly related to aldosterone in PCOS. Conclusion: PCOS women show an insulin resistance related increase in serum aldosterone levels.Keywords
This publication has 39 references indexed in Scilit:
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life SpanThe Journal of Clinical Endocrinology & Metabolism, 2005
- Aldosterone as a cardiovascular risk factorTrends in Endocrinology & Metabolism, 2005
- The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2005
- Aldosterone in heart failure: Pathophysiology and treatmentCurrent Heart Failure Reports, 2004
- Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2004
- Polycystic ovary syndrome: A risk for coronary artery disease?American Journal of Obstetrics and Gynecology, 2002
- Pathophysiological effects of aldosterone in cardiovascular tissuesTrends in Endocrinology & Metabolism, 2001
- Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndromeHuman Reproduction, 2000
- Coronary Heart Disease Risk Factors in Women With Polycystic Ovary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitusThe American Journal of Medicine, 1995